348 related articles for article (PubMed ID: 25325325)
1. Can breast cancer molecular subtype help to select patients for preoperative MR imaging?
Grimm LJ; Johnson KS; Marcom PK; Baker JA; Soo MS
Radiology; 2015 Feb; 274(2):352-8. PubMed ID: 25325325
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer molecular subtype as a predictor of the utility of preoperative MRI.
Ha R; Jin B; Mango V; Friedlander L; Miloshev V; Malak S; Wynn R
AJR Am J Roentgenol; 2015 Jun; 204(6):1354-60. PubMed ID: 26001248
[TBL] [Abstract][Full Text] [Related]
3. Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms.
Grimm LJ; Zhang J; Mazurowski MA
J Magn Reson Imaging; 2015 Oct; 42(4):902-7. PubMed ID: 25777181
[TBL] [Abstract][Full Text] [Related]
4. Presenting features of breast cancer differ by molecular subtype.
Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
[TBL] [Abstract][Full Text] [Related]
5. Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.
Crabb SJ; Cheang MC; Leung S; Immonen T; Nielsen TO; Huntsman DD; Bajdik CD; Chia SK
Clin Breast Cancer; 2008 Jun; 8(3):249-56. PubMed ID: 18650155
[TBL] [Abstract][Full Text] [Related]
6. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
[TBL] [Abstract][Full Text] [Related]
7. The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival.
Vasconcelos I; Hussainzada A; Berger S; Fietze E; Linke J; Siedentopf F; Schoenegg W
Breast; 2016 Oct; 29():181-5. PubMed ID: 27544822
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.
Munzone E; Botteri E; Sandri MT; Esposito A; Adamoli L; Zorzino L; Sciandivasci A; Cassatella MC; Rotmensz N; Aurilio G; Curigliano G; Goldhirsch A; Nolè F
Clin Breast Cancer; 2012 Oct; 12(5):340-6. PubMed ID: 23040002
[TBL] [Abstract][Full Text] [Related]
9. [Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features].
Hao L; Yu RS; Cui F; Ren XC; Xu HB; Xu KY
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):819-23. PubMed ID: 23859386
[TBL] [Abstract][Full Text] [Related]
10. Descriptive analysis of molecular subtypes in Tunisian breast cancer.
Fourati A; Boussen H; El May MV; Goucha A; Dabbabi B; Gamoudi A; Sfar R; Rahal K; El May A; Ben Abdallah M
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e69-74. PubMed ID: 23176549
[TBL] [Abstract][Full Text] [Related]
11. Preoperative MRI Evaluation of Axillary Lymph Nodes in Invasive Ductal Carcinoma: Comparison of Luminal A Versus Luminal B Subtypes in a Paradigm Using Ki-67 and Receptor Status.
Plaza MJ; Handa P; Esserman LE
AJR Am J Roentgenol; 2017 Apr; 208(4):910-915. PubMed ID: 28140614
[TBL] [Abstract][Full Text] [Related]
12. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results.
Makkat S; Luypaert R; Stadnik T; Bourgain C; Sourbron S; Dujardin M; De Greve J; De Mey J
Radiology; 2008 Nov; 249(2):471-82. PubMed ID: 18780825
[TBL] [Abstract][Full Text] [Related]
13. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.
Del Casar JM; Martín A; García C; Corte MD; Alvarez A; Junquera S; González LO; Bongera M; García-Muñiz JL; Allende MT; Vizoso F
Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):147-52. PubMed ID: 18768247
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
Uematsu T; Kasami M; Yuen S
Radiology; 2009 Mar; 250(3):638-47. PubMed ID: 19244039
[TBL] [Abstract][Full Text] [Related]
15. Lymph node involvement in immunohistochemistry-based molecular classifications of breast cancer.
Howland NK; Driver TD; Sedrak MP; Wen X; Dong W; Hatch S; Eltorky MA; Chao C
J Surg Res; 2013 Dec; 185(2):697-703. PubMed ID: 24095025
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression.
Wang Y; Ikeda DM; Narasimhan B; Longacre TA; Bleicher RJ; Pal S; Jackman RJ; Jeffrey SS
Radiology; 2008 Feb; 246(2):367-75. PubMed ID: 18180338
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
Wang Y; Yin Q; Yu Q; Zhang J; Liu Z; Wang S; Lv S; Niu Y
Breast Cancer Res Treat; 2011 Nov; 130(2):489-98. PubMed ID: 21837481
[TBL] [Abstract][Full Text] [Related]
20. Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.
Grimm LJ; Zhang J; Baker JA; Soo MS; Johnson KS; Mazurowski MA
Breast J; 2017 Sep; 23(5):579-582. PubMed ID: 28295860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
